APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DPT Series Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global DPT Series Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173985980329 December 2025193 pages

Choose your research edition.

Industry ResearchDPT Series Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal DPT Series Vaccine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal DPT Series Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DPT Series Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal DPT Series Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global DPT Series Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for DPT Series Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DPT Series Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DPT Series Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for DPT Series Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of DPT Series Vaccine include AJ Vaccines, GSK, Panacea Biotec, Sanofi, Hualan Biological Vaccine, BioKangtai, CanSino Biologics, Walvax Biotechnology and CNBG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DPT Series Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DPT Series Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DPT Series Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DPT Series Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

DPT Series Vaccine Segment by Company

AJ Vaccines

GSK

Panacea Biotec

Sanofi

Hualan Biological Vaccine

BioKangtai

CanSino Biologics

Walvax Biotechnology

CNBG

Chongqing Zhifei Biological Products

DPT Series Vaccine Segment by Type

Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine

Absorbed Tetanus Vaccine

Absorbed Diphtheria-Tetanus Combined Vaccine

DTP-IPV-Hib Pentavalent Vaccine

DTP-Hib Quadruple Vaccine

DPT Series Vaccine Segment by Application

Adults

Children

DPT Series Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DPT Series Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DPT Series Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DPT Series Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DPT Series Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DPT Series Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of DPT Series Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of DPT Series Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. DPT Series Vaccine Industry Trends Table 2. DPT Series Vaccine Industry Drivers Table 3. DPT Series Vaccine Industry Opportunities and Challenges Table 4. DPT Series Vaccine Industry Restraints Table 5. Global DPT Series Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global DPT Series Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global DPT Series Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global DPT Series Vaccine Sales Market Share by Manufacturers Table 9. Global DPT Series Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global DPT Series Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global DPT Series Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global DPT Series Vaccine Manufacturers, Product Type & Application Table 13. Global DPT Series Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global DPT Series Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine Table 17. Major Manufacturers of Absorbed Tetanus Vaccine Table 18. Major Manufacturers of Absorbed Diphtheria-Tetanus Combined Vaccine Table 19. Major Manufacturers of DTP-IPV-Hib Pentavalent Vaccine Table 20. Major Manufacturers of DTP-Hib Quadruple Vaccine Table 21. Global DPT Series Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global DPT Series Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Global DPT Series Vaccine Sales by Type (2027-2032) & (K Units) Table 24. Global DPT Series Vaccine Sales Market Share by Type (2021-2026) Table 25. Global DPT Series Vaccine Sales Market Share by Type (2027-2032) Table 26. Global DPT Series Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global DPT Series Vaccine Revenue by Type (2021-2026) & (K Units) Table 28. Global DPT Series Vaccine Revenue by Type (2027-2032) & (K Units) Table 29. Global DPT Series Vaccine Revenue Market Share by Type (2021-2026) Table 30. Global DPT Series Vaccine Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Adults Table 32. Major Manufacturers of Children Table 33. Global DPT Series Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global DPT Series Vaccine Sales by Application (2021-2026) & (K Units) Table 35. Global DPT Series Vaccine Sales by Application (2027-2032) & (K Units) Table 36. Global DPT Series Vaccine Sales Market Share by Application (2021-2026) Table 37. Global DPT Series Vaccine Sales Market Share by Application (2027-2032) Table 38. Global DPT Series Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global DPT Series Vaccine Revenue by Application (2021-2026) & (K Units) Table 40. Global DPT Series Vaccine Revenue by Application (2027-2032) & (K Units) Table 41. Global DPT Series Vaccine Revenue Market Share by Application (2021-2026) Table 42. Global DPT Series Vaccine Revenue Market Share by Application (2027-2032) Table 43. Global DPT Series Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global DPT Series Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global DPT Series Vaccine Sales Market Share by Region (2021-2026) Table 46. Global DPT Series Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global DPT Series Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 48. North America DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 50. North America DPT Series Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Europe DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Europe DPT Series Vaccine Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific DPT Series Vaccine Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa DPT Series Vaccine Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa DPT Series Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global DPT Series Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global DPT Series Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 62. Global DPT Series Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 63. Global DPT Series Vaccine Revenue Market Share by Region (2021-2026) Table 64. Global DPT Series Vaccine Revenue Market Share by Region (2027-2032) Table 65. AJ Vaccines Company Information Table 66. AJ Vaccines Business Overview Table 67. AJ Vaccines DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. AJ Vaccines DPT Series Vaccine Product Portfolio Table 69. AJ Vaccines Recent Development Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. GSK DPT Series Vaccine Product Portfolio Table 74. GSK Recent Development Table 75. Panacea Biotec Company Information Table 76. Panacea Biotec Business Overview Table 77. Panacea Biotec DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Panacea Biotec DPT Series Vaccine Product Portfolio Table 79. Panacea Biotec Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sanofi DPT Series Vaccine Product Portfolio Table 84. Sanofi Recent Development Table 85. Hualan Biological Vaccine Company Information Table 86. Hualan Biological Vaccine Business Overview Table 87. Hualan Biological Vaccine DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Hualan Biological Vaccine DPT Series Vaccine Product Portfolio Table 89. Hualan Biological Vaccine Recent Development Table 90. BioKangtai Company Information Table 91. BioKangtai Business Overview Table 92. BioKangtai DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. BioKangtai DPT Series Vaccine Product Portfolio Table 94. BioKangtai Recent Development Table 95. CanSino Biologics Company Information Table 96. CanSino Biologics Business Overview Table 97. CanSino Biologics DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. CanSino Biologics DPT Series Vaccine Product Portfolio Table 99. CanSino Biologics Recent Development Table 100. Walvax Biotechnology Company Information Table 101. Walvax Biotechnology Business Overview Table 102. Walvax Biotechnology DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Walvax Biotechnology DPT Series Vaccine Product Portfolio Table 104. Walvax Biotechnology Recent Development Table 105. CNBG Company Information Table 106. CNBG Business Overview Table 107. CNBG DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. CNBG DPT Series Vaccine Product Portfolio Table 109. CNBG Recent Development Table 110. Chongqing Zhifei Biological Products Company Information Table 111. Chongqing Zhifei Biological Products Business Overview Table 112. Chongqing Zhifei Biological Products DPT Series Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolio Table 114. Chongqing Zhifei Biological Products Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. DPT Series Vaccine Distributors List Table 118. DPT Series Vaccine Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. DPT Series Vaccine Product Image Figure 2. Global DPT Series Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DPT Series Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global DPT Series Vaccine Sales (2021-2032) & (K Units) Figure 5. Global DPT Series Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 DPT Series Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine Image Figure 9. Absorbed Tetanus Vaccine Image Figure 10. Absorbed Diphtheria-Tetanus Combined Vaccine Image Figure 11. DTP-IPV-Hib Pentavalent Vaccine Image Figure 12. DTP-Hib Quadruple Vaccine Image Figure 13. Global DPT Series Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global DPT Series Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global DPT Series Vaccine Sales Market Share by Type (2021-2032) Figure 16. Global DPT Series Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global DPT Series Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global DPT Series Vaccine Revenue Market Share by Type (2021-2032) Figure 19. Adults Image Figure 20. Children Image Figure 21. Global DPT Series Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global DPT Series Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global DPT Series Vaccine Sales Market Share by Application (2021-2032) Figure 24. Global DPT Series Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global DPT Series Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global DPT Series Vaccine Revenue Market Share by Application (2021-2032) Figure 27. North America DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America DPT Series Vaccine Sales Market Share by Country (2021-2032) Figure 29. U.S. DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe DPT Series Vaccine Sales Market Share by Country (2021-2032) Figure 34. Germany DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific DPT Series Vaccine Sales Market Share by Country (2021-2032) Figure 41. China DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa DPT Series Vaccine Sales Market Share by Country (2021-2032) Figure 49. Brazil DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile DPT Series Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global DPT Series Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global DPT Series Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America DPT Series Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. North America DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe DPT Series Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Europe DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific DPT Series Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa DPT Series Vaccine Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. DPT Series Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. DPT Series Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
  • Absorbed Tetanus Vaccine
  • Absorbed Diphtheria-Tetanus Combined Vaccine
  • DTP-IPV-Hib Pentavalent Vaccine
  • DTP-Hib Quadruple Vaccine
Applications
  • Adults
  • Children
Companies covered
  • AJ Vaccines
  • GSK
  • Panacea Biotec
  • Sanofi
  • Hualan Biological Vaccine
  • BioKangtai
  • CanSino Biologics
  • Walvax Biotechnology
  • CNBG
  • Chongqing Zhifei Biological Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DPT Series Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DPT Series Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global DPT Series Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global DPT Series Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global DPT Series Vaccine Market Dynamics
  1. 2.1 DPT Series Vaccine Industry Trends
  2. 2.2 DPT Series Vaccine Industry Drivers
  3. 2.3 DPT Series Vaccine Industry Opportunities and Challenges
  4. 2.4 DPT Series Vaccine Industry Restraints
3 DPT Series Vaccine Market by Manufacturers
  1. 3.1 Global DPT Series Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global DPT Series Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global DPT Series Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global DPT Series Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DPT Series Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global DPT Series Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global DPT Series Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DPT Series Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DPT Series Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DPT Series Vaccine Tier 1, Tier 2, and Tier 3
4 DPT Series Vaccine Market by Type
  1. 4.1 DPT Series Vaccine Type Introduction
  2. 4.1.1 Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
  3. 4.1.2 Absorbed Tetanus Vaccine
  4. 4.1.3 Absorbed Diphtheria-Tetanus Combined Vaccine
  5. 4.1.4 DTP-IPV-Hib Pentavalent Vaccine
  6. 4.1.5 DTP-Hib Quadruple Vaccine
  7. 4.2 Global DPT Series Vaccine Sales by Type
  8. 4.2.1 Global DPT Series Vaccine Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global DPT Series Vaccine Sales by Type (2021-2032)
  10. 4.2.3 Global DPT Series Vaccine Sales Market Share by Type (2021-2032)
  11. 4.3 Global DPT Series Vaccine Revenue by Type
  12. 4.3.1 Global DPT Series Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global DPT Series Vaccine Revenue by Type (2021-2032)
  14. 4.3.3 Global DPT Series Vaccine Revenue Market Share by Type (2021-2032)
5 DPT Series Vaccine Market by Application
  1. 5.1 DPT Series Vaccine Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global DPT Series Vaccine Sales by Application
  5. 5.2.1 Global DPT Series Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DPT Series Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global DPT Series Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global DPT Series Vaccine Revenue by Application
  9. 5.3.1 Global DPT Series Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DPT Series Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global DPT Series Vaccine Revenue Market Share by Application (2021-2032)
6 Global DPT Series Vaccine Sales by Region
  1. 6.1 Global DPT Series Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DPT Series Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global DPT Series Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global DPT Series Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America DPT Series Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe DPT Series Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific DPT Series Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa DPT Series Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa DPT Series Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global DPT Series Vaccine Revenue by Region
  1. 7.1 Global DPT Series Vaccine Revenue by Region
  2. 7.1.1 Global DPT Series Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global DPT Series Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global DPT Series Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global DPT Series Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America DPT Series Vaccine Revenue (2021-2032)
  8. 7.2.2 North America DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe DPT Series Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific DPT Series Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa DPT Series Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa DPT Series Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AJ Vaccines
  2. 8.1.1 AJ Vaccines Company Information
  3. 8.1.2 AJ Vaccines Business Overview
  4. 8.1.3 AJ Vaccines DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AJ Vaccines DPT Series Vaccine Product Portfolio
  6. 8.1.5 AJ Vaccines Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK DPT Series Vaccine Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 Panacea Biotec
  14. 8.3.1 Panacea Biotec Company Information
  15. 8.3.2 Panacea Biotec Business Overview
  16. 8.3.3 Panacea Biotec DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Panacea Biotec DPT Series Vaccine Product Portfolio
  18. 8.3.5 Panacea Biotec Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi DPT Series Vaccine Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Hualan Biological Vaccine
  26. 8.5.1 Hualan Biological Vaccine Company Information
  27. 8.5.2 Hualan Biological Vaccine Business Overview
  28. 8.5.3 Hualan Biological Vaccine DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hualan Biological Vaccine DPT Series Vaccine Product Portfolio
  30. 8.5.5 Hualan Biological Vaccine Recent Developments
  31. 8.6 BioKangtai
  32. 8.6.1 BioKangtai Company Information
  33. 8.6.2 BioKangtai Business Overview
  34. 8.6.3 BioKangtai DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BioKangtai DPT Series Vaccine Product Portfolio
  36. 8.6.5 BioKangtai Recent Developments
  37. 8.7 CanSino Biologics
  38. 8.7.1 CanSino Biologics Company Information
  39. 8.7.2 CanSino Biologics Business Overview
  40. 8.7.3 CanSino Biologics DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CanSino Biologics DPT Series Vaccine Product Portfolio
  42. 8.7.5 CanSino Biologics Recent Developments
  43. 8.8 Walvax Biotechnology
  44. 8.8.1 Walvax Biotechnology Company Information
  45. 8.8.2 Walvax Biotechnology Business Overview
  46. 8.8.3 Walvax Biotechnology DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Walvax Biotechnology DPT Series Vaccine Product Portfolio
  48. 8.8.5 Walvax Biotechnology Recent Developments
  49. 8.9 CNBG
  50. 8.9.1 CNBG Company Information
  51. 8.9.2 CNBG Business Overview
  52. 8.9.3 CNBG DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CNBG DPT Series Vaccine Product Portfolio
  54. 8.9.5 CNBG Recent Developments
  55. 8.10 Chongqing Zhifei Biological Products
  56. 8.10.1 Chongqing Zhifei Biological Products Company Information
  57. 8.10.2 Chongqing Zhifei Biological Products Business Overview
  58. 8.10.3 Chongqing Zhifei Biological Products DPT Series Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolio
  60. 8.10.5 Chongqing Zhifei Biological Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DPT Series Vaccine Value Chain Analysis
  2. 9.1.1 DPT Series Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DPT Series Vaccine Production Mode & Process
  6. 9.2 DPT Series Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DPT Series Vaccine Distributors
  9. 9.2.3 DPT Series Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst